Avadel Pharmaceuticals Plc Stock Price on May 1, 2024
| AVDL Stock | USD 15.95 0.19 1.21% |
Below is the normalized historical share price chart for Avadel Pharmaceuticals PLC extending back to June 07, 1996. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Avadel Pharmaceuticals stands at 15.95, as last reported on the 3rd of June, with the highest price reaching 16.00 and the lowest price hitting 15.57 during the day.
If you're considering investing in Avadel Stock, it is important to understand the factors that can impact its price. We consider Avadel Pharmaceuticals not too volatile. Avadel Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0185, which signifies that the company had a 0.0185% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Avadel Pharmaceuticals PLC, which you can use to evaluate the volatility of the firm. Please confirm Avadel Pharmaceuticals' mean deviation of 2.27, and Risk Adjusted Performance of 0.0834 to double-check if the risk estimate we provide is consistent with the expected return of 0.0496%.
At this time, Avadel Pharmaceuticals' Stock Based Compensation To Revenue is quite stable compared to the past year. . At this time, Avadel Pharmaceuticals' Price Fair Value is quite stable compared to the past year. Avadel Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 7th of June 1996 | 200 Day MA 13.9496 | 50 Day MA 16.8214 | Beta 1.632 |
Avadel |
Sharpe Ratio = 0.0185
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AVDL |
Estimated Market Risk
| 2.68 actual daily | 23 77% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Avadel Pharmaceuticals is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Avadel Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 16.517 | Enterprise Value Ebitda (9.03) | Price Sales 51.7944 | Shares Float 95.4 M | Wall Street Target Price 23.65 |
Avadel Pharmaceuticals Main Headline on 1st of May 2024
Avadel Pharmaceuticals to Provide a Corporate Update and Rep... by finance.yahoo.com
DUBLIN, Ireland, May 01, 2024 -- Avadel Pharmaceuticals plc , a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 830 a.m. ET on Wednesday, May 8, 2024, to provide a corporate update and discuss the Companys financial results for the first quarter ended March 31, 2024. To access the conference call, investors are invited to dial 1 715-9871 U.S. and Canada
Avadel Pharmaceuticals Valuation on May 1, 2024
It is possible to determine the worth of Avadel Pharmaceuticals on a given historical date. On May 1, 2024 Avadel was worth 18.39 at the beginning of the trading date compared to the closed value of 18.31. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Avadel Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Avadel Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Avadel Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Avadel Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 17.90 | 18.65 | 17.85 | 18.16 | 849,696 | |
05/01/2024 | 18.39 | 19.04 | 18.23 | 18.31 | 1,032,772 |
| 18.39 | 18.66 | 17.73 | 18.30 | 849,156 |
| Backtest Avadel Pharmaceuticals | | | Avadel Pharmaceuticals History | | | Avadel Pharmaceuticals Valuation | Previous | Next |
Avadel Pharmaceuticals Trading Date Momentum on May 1, 2024
| On May 02 2024 Avadel Pharmaceuticals PLC was traded for 18.30 at the closing time. The top price for the day was 18.66 and the lowest listed price was 17.73 . The trading volume for the day was 849.2 K. The trading history from May 2, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.05% . The overall trading delta against the current closing price is 9.61% . |
Avadel Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Avadel Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Avadel Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Avadel financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Avadel Pharmaceuticals Stock history
Avadel Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Avadel is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Avadel Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Avadel Pharmaceuticals stock prices may prove useful in developing a viable investing in Avadel Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 80.2 M | 84.2 M | |
| Net Loss | -123.7 M | -117.5 M |
Avadel Pharmaceuticals Quarterly Net Working Capital |
|
Avadel Pharmaceuticals Stock Technical Analysis
Avadel Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Avadel Pharmaceuticals Period Price Range
Low | May 1, 2024
| High |
18.39 | 18.31 |
Avadel Pharmaceuticals June 3, 2024 Market Strength
Market strength indicators help investors to evaluate how Avadel Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Avadel Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Avadel Pharmaceuticals stock market strength indicators, traders can identify Avadel Pharmaceuticals PLC entry and exit signals to maximize returns
| Accumulation Distribution | 43936.2 | |||
| Daily Balance Of Power | (0.1) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 18.63 | |||
| Day Typical Price | 18.53 | |||
| Price Action Indicator | (0.37) | |||
| Period Momentum Indicator | (2.36) |
Avadel Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Avadel Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Avadel Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Avadel to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0834 | |||
| Jensen Alpha | 0.3855 | |||
| Total Risk Alpha | 0.2143 | |||
| Sortino Ratio | 0.1384 | |||
| Treynor Ratio | 0.5358 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avadel Pharmaceuticals PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Avadel Pharmaceuticals information on this page should be used as a complementary analysis to other Avadel Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Avadel Stock analysis
When running Avadel Pharmaceuticals' price analysis, check to measure Avadel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avadel Pharmaceuticals is operating at the current time. Most of Avadel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Avadel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avadel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Avadel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Avadel Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avadel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.82) | Revenue Per Share 0.633 | Quarterly Revenue Growth (1.00) | Return On Assets (0.55) | Return On Equity (7.80) |
The market value of Avadel Pharmaceuticals is measured differently than its book value, which is the value of Avadel that is recorded on the company's balance sheet. Investors also form their own opinion of Avadel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Avadel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avadel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Avadel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avadel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avadel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avadel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.